Ranch Capital Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20,381
Closed -$1.78M 159
2026
Q1
$1.78M Buy
20,381
+599
+3% +$57.4K 0.64% 52
2025
Q4
$1.91M Buy
19,782
+946
+5% +$91.9K 0.7% 44
2025
Q3
$1.8M Buy
+18,836
New +$1.73M 0.7% 46
2024
Q2
Sell
-9,382
Closed -$822K 157
2024
Q1
$822K Buy
9,382
+188
+2% +$16K 0.44% 65
2023
Q4
$762K Buy
9,194
+506
+6% +$38.6K 0.48% 65
2023
Q3
$685K Sell
8,688
-992
-10% -$83K 0.48% 66
2023
Q2
$858K Sell
9,680
-105
-1% -$9.04K 0.6% 51
2023
Q1
$789K Buy
+9,785
New +$798K 0.58% 56
2021
Q4
Sell
-97
Closed -$12K 384
2021
Q3
$12K Buy
97
+1
+1% +$129 0.01% 448
2021
Q2
$12K Sell
96
-15
-14% -$1.88K 0.01% 607
2021
Q1
$13K Hold
111
0.01% 582
2020
Q4
$13K Hold
111
0.01% 578
2020
Q3
$11K Sell
111
-72
-39% -$7.23K 0.01% 591
2020
Q2
$18K Sell
183
-145
-44% -$13.9K 0.01% 497
2020
Q1
$29K Sell
328
-119
-27% -$12.7K 0.03% 369
2019
Q4
$51K Buy
+447
New +$49K 0.04% 332

Other funds holding MDT

Ranch Capital Advisors's MDT Position: Q2 2026 in Review

Ranch Capital Advisors sold out of Medtronic (MDT) in Q2 2026, closing a stake of 20,381 shares — an estimated $1.78M sold.

Ranch Capital Advisors first reported a position in MDT in Q4 2019 and held it in 16 quarters. The position peaked at $1.91M in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Ranch Capital Advisors reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Ranch Capital Advisors sold 20,381 Medtronic shares in Q2 2026, an estimated $1.78M.
  • Ranch Capital Advisors first reported a position in Medtronic in Q4 2019 and held it in 16 quarters.
  • Ranch Capital Advisors's Medtronic position peaked at $1.91M in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Ranch Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.